MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Amini A. et al, (2025), Sci Immunol, 10
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
O'Connor D. et al, (2025), Nat Commun, 16
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Pinto MV. et al, (2024), J Immunol Methods, 534
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Maytum A. et al, (2024), Pediatr Infect Dis J
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
Dold C. et al, (2023), Sci Transl Med, 15
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials
EWER K., (2023), Clinical and Experimental Immunology
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Mentzer AJ. et al, (2023), Nat Med, 29, 147 - 157
Regulatory T cell profiles in patients with N-methyl-ᴅ-aspartate receptor-antibody encephalitis.
Iro MA. et al, (2023), Encephalitis, 3, 15 - 23
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Shaw RH. et al, (2022), Lancet Respir Med, 10, 1049 - 1060
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Rollier CS. et al, (2022), Vaccine, 40, 4453 - 4463
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Marchevsky NG. et al, (2022), EBioMedicine, 81
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Tomic A. et al, (2022), Nat Commun, 13
Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
Versteegen P. et al, (2022), Front Immunol, 13